v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Information [Abstract]  
Schedule of Significant Expense Categories of the Company’s Single Operating Segment The following table presents the significant expense categories of the Company’s single operating segment for the periods presented.
   For the three months ended
March 31,		 
   2026   2025 
   (Unaudited)   (Unaudited) 
Operating expenses:        
Clinical trial related service fee to related party (Note 5)  $1,375,000   $1,375,000 
Consulting fee   15,000    25,000 
Stock-based compensation (Note 8)   146,714    159,095 
Salary expense   128,764    129,711 
Professional fee   398,133    285,090 
Insurance expense   79,339    81,057 
Other general and administrative fee   149,114    49,345 
Loss before income tax   2,292,064    2,104,298 
           
Income tax expense   
-
    13 
Net loss  $2,292,064   $2,104,311